Jolt Health Inc.
JOLT
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -84.23% | 2.97% | 686.96% | 48.01% | 68.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -84.23% | 2.97% | 686.96% | 48.01% | 68.17% |
| Operating Income | 84.23% | -2.97% | -686.96% | -48.01% | -68.17% |
| Income Before Tax | 82.04% | -6.48% | -121.93% | -139.62% | -34.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 82.04% | -6.48% | -121.93% | -139.62% | -34.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.04% | -6.48% | -121.93% | -139.62% | -34.87% |
| EBIT | 84.23% | -2.97% | -686.96% | -48.01% | -68.17% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 82.01% | 33.59% | -35.04% | -15.94% | 43.23% |
| Normalized Basic EPS | 81.88% | 33.47% | -483.56% | -16.28% | 43.35% |
| EPS Diluted | 82.01% | 33.59% | -35.04% | -15.94% | 43.23% |
| Normalized Diluted EPS | 81.88% | 33.47% | -483.56% | -16.28% | 43.35% |
| Average Basic Shares Outstanding | 0.00% | 60.13% | 64.51% | 108.39% | 137.93% |
| Average Diluted Shares Outstanding | 0.00% | 60.13% | 64.51% | 108.39% | 137.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |